WHO Allows Early Purchase Talks for Mpox Vaccines to Expedite African Distribution

Partners like Gavi and UNICEF can negotiate vaccine orders before WHO approval to address escalating outbreak

The WHO's decision aims to fast-track vaccine availability in Africa amid a growing mpox outbreak.
Traditionally, organizations like Gavi wait for WHO approval before purchasing vaccines.
Two vaccines from Bavarian Nordic and KM Biologics are already approved in several countries and widely used.
WHO's emergency license for these vaccines is expected by mid-September.
Bavarian Nordic emphasizes the need for immediate orders to ensure vaccine supply for lower-income countries.